Healthcare provider profile · identity verified

Michael J Mitchko, M.D.

Internal Medicine · CANANDAIGUA, NY · NPI 1811990898

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	933	245
Levothyroxine Sodium	Levothyroxine Sodium	664	154
Lisinopril	Lisinopril	569	151
Amlodipine Besylate	Amlodipine Besylate	562	134
Omeprazole	Omeprazole	401	107
Meloxicam	Meloxicam	390	119
Gabapentin	Gabapentin	380	98
Sertraline Hcl	Sertraline Hcl	330	86
Losartan Potassium	Losartan Potassium	318	80
Metoprolol Succinate	Metoprolol Succinate	303	79
Simvastatin	Simvastatin	303	72
Valsartan	Valsartan	263	62
Hydrochlorothiazide	Hydrochlorothiazide	248	70
Metformin Hcl Er	Metformin Hcl	236	64
Tamsulosin Hcl	Tamsulosin Hcl	219	53
Pantoprazole Sodium	Pantoprazole Sodium	213	48
Glimepiride	Glimepiride	195	49
Eliquis	Apixaban	179	33
Allopurinol	Allopurinol	171	38
Pravastatin Sodium	Pravastatin Sodium	158	43
Famotidine	Famotidine	149	41
Albuterol Sulfate Hfa	Albuterol Sulfate	144	42
Duloxetine Hcl	Duloxetine Hcl	128	24
Felodipine Er	Felodipine	128	27
Rosuvastatin Calcium	Rosuvastatin Calcium	127	35
Fluoxetine Hcl	Fluoxetine Hcl	123	24
Jardiance	Empagliflozin	120	23
Metformin Hcl	Metformin Hcl	120	34
Atenolol	Atenolol	119	34
Potassium Chloride	Potassium Chloride	118	26
Metoprolol Tartrate	Metoprolol Tartrate	109	28
Alprazolam	Alprazolam	104	29
Zolpidem Tartrate	Zolpidem Tartrate	101	23
Warfarin Sodium	Warfarin Sodium	96	25
Alendronate Sodium	Alendronate Sodium	92	20
Hydroxyzine Hcl	Hydroxyzine Hcl	89	29
Prednisone	Prednisone	86	64
Furosemide	Furosemide	85	27
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	80	suppressed
Fluticasone Propionate	Fluticasone Propionate	75	27
Citalopram Hbr	Citalopram Hydrobromide	74	19
Enalapril Maleate	Enalapril Maleate	74	19
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	72	40
Escitalopram Oxalate	Escitalopram Oxalate	72	21
Lovastatin	Lovastatin	72	20
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	69	16
Glipizide Er	Glipizide	68	21
Trazodone Hcl	Trazodone Hcl	66	suppressed
Clopidogrel	Clopidogrel Bisulfate	64	16
Doxycycline Hyclate	Doxycycline Hyclate	63	48
Oxybutynin Chloride Er	Oxybutynin Chloride	63	16
Torsemide	Torsemide	63	16
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	61	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	60	16
Amoxicillin	Amoxicillin	58	53
Irbesartan	Irbesartan	58	16
Montelukast Sodium	Montelukast Sodium	58	16
Oxycodone Hcl	Oxycodone Hcl	58	15
Tramadol Hcl	Tramadol Hcl	57	16
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	56	14
Bupropion Xl	Bupropion Hcl	53	16
Synthroid	Levothyroxine Sodium	53	11
Venlafaxine Hcl Er	Venlafaxine Hcl	46	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	44	suppressed
Xarelto	Rivaroxaban	44	suppressed
Finasteride	Finasteride	43	12
Mirtazapine	Mirtazapine	43	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	39	suppressed
Breo Ellipta	Fluticasone/Vilanterol	38	suppressed
Paroxetine Hcl	Paroxetine Hcl	37	suppressed
Buspirone Hcl	Buspirone Hcl	35	suppressed
Azithromycin	Azithromycin	34	28
Meclizine Hcl	Meclizine Hcl	34	18
Eszopiclone	Eszopiclone	33	suppressed
Januvia	Sitagliptin Phosphate	33	suppressed
Ibuprofen	Ibuprofen	32	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	32	suppressed
Carvedilol	Carvedilol	31	suppressed
Lorazepam	Lorazepam	31	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	31	suppressed
Ozempic	Semaglutide	31	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	30	suppressed
Glipizide	Glipizide	30	suppressed
Donepezil Hcl	Donepezil Hcl	29	suppressed
Solifenacin Succinate	Solifenacin Succinate	29	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	29	17
Hydromorphone Hcl	Hydromorphone Hcl	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	suppressed
Baclofen	Baclofen	27	suppressed
Cephalexin	Cephalexin	27	16
Spironolactone	Spironolactone	27	suppressed
Ropinirole Hcl	Ropinirole Hcl	26	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	26	21
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	25	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	23	suppressed
Labetalol Hcl	Labetalol Hcl	23	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	23	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	22	suppressed
Fosinopril Sodium	Fosinopril Sodium	22	suppressed
Gemfibrozil	Gemfibrozil	22	suppressed
Nifedipine Er	Nifedipine	22	suppressed
Pregabalin	Pregabalin	22	suppressed
Valacyclovir	Valacyclovir Hcl	22	15
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	21	13
Lansoprazole	Lansoprazole	21	suppressed
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	21	suppressed
Chlorthalidone	Chlorthalidone	20	suppressed
Diclofenac Sodium	Diclofenac Sodium	20	suppressed
Diazepam	Diazepam	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	18	suppressed
Trulicity	Dulaglutide	18	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	18	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	17	17
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	17	suppressed
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Celecoxib	Celecoxib	16	suppressed
Humalog Kwikpen U-100	Insulin Lispro	16	suppressed
Invokana	Canagliflozin	16	suppressed
Ketoconazole	Ketoconazole	16	12
Midodrine Hcl	Midodrine Hcl	16	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	16
Tolterodine Tartrate Er	Tolterodine Tartrate	16	suppressed
Ventolin Hfa	Albuterol Sulfate	16	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	15	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	15	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	14	suppressed
Arnuity Ellipta	Fluticasone Furoate	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	14	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Fenofibrate	Fenofibrate	14	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	14	suppressed
Methadone Hcl	Methadone Hcl	14	suppressed
Sildenafil Citrate	Sildenafil Citrate	14	suppressed
Humalog Mix 75-25 Kwikpen	Insulin Lispro Protamin/Lispro	13	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	13	suppressed
Promethazine Hcl	Promethazine Hcl	13	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	12	suppressed
Ipratropium Bromide	Ipratropium Bromide	12	suppressed
Morphine Sulfate Er	Morphine Sulfate	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	12
Ultra-Fine Micro Pen Needle	Pen Needle, Diabetic	12	suppressed
Advair Diskus	Fluticasone Propion/Salmeterol	11	suppressed
Clotrimazole	Clotrimazole	11	suppressed
Dulera	Mometasone/Formoterol	11	suppressed
Naproxen	Naproxen	11	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error